IL-37 enhances the expression of antiangiogenic factors while concurrently reducing the expression of proangiogenic factors by tumour cells, thereby inhibiting tumoral angiogenesis within the tumour microenvironment (38). This evidence concerns the gene IL37 and neoplasm.